How AI Transforms Regulatory Submission: Current Clinical Implementation and Future Prospects
Clinical and Translational Science2025Vol. 18(12), pp. e70434–e70434
Jagdeep T. Podichetty, Anna‐Marika Bauer, Rachel Xu, Nick Henscheid, Wes Anderson, Adnan Shahid Khan, Shu Chin, Hien Q. Huynh, Klaus Romero
Abstract
Artificial Intelligence (AI) is transforming drug development and regulatory submission by enabling advanced data analytics, predictive modeling and intelligent decision support systems. Beyond efficiency gains, AI establishes a translational bridge between model-informed drug development (MIDD) and clinical implementation, turning regulatory evidence into actionable insights that enhance therapeutic precision and patient outcomes. This perspective paper explores AI's current applications, regulatory integrations, and future prospects in accelerating data-driven, patient-centered drug development.